Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • A Phase 3 Randomized Double-blind Placebo-controlled Parallel-group Multicenter Study to Evaluate the Efficacy Safety and Tolerability of LX4211 as Adjunct Therapy in Adult Patients with Type 1Diabetes Mellitus Who Have Inadequate Glycemic Control

    View Trial
  • RAIDER

    A Randomised phase II trial of Adaptive Image guided standard or Dose Escalated tumour boost Radiotherapy in the treatment of transitional cell carcinoma of the bladder

    View Trial
  • Autophagy and Metabolism in Autoimmunity

    The Role of Autophagy and Metabolism in Autoimmunity

    View Trial
  • The BLUEBELLE Study: Phase B

    The Bluebelle study: Feasibility study of complex simple and absent wound dressings in elective surgery (Phase B)

    View Trial
  • Development of health-related quality of life scales for patients and parents affected by Niemann-Pick Disease Type C

    View Trial
  • Investigation of virtual restorative environment therapy to aid pain control during dry burns dressing changes

    View Trial
  • Organising Improvement: Regulating Patient Safety from Blunt to Sharp End

    View Trial
  • A multi centre double blind double dummy randomised positive controlled study comparing the efficacy and safety of Lacosamide (200 to 600mg/day) to controlled release Carbamazepine (400 to 1200mg/day) used as Monotherapy in subjects (=16 years) newly or recently diagnosed with Epilepsy and experiencing partial onset or generalised Tonic Clonic Seizures

    View Trial
  • Cogwatch

    Cognitive Rehabilitation of Apraxia and Action Disorganisation Syndrome

    View Trial
  • The ACQUATIK Study

    Acute Care QUAliTy in chronic Kidney Disease

    View Trial